SEC Form 4 · accession 0001655016-26-000003
Edgewise Therapeutics, Inc. · EWTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan C Fox
Director
Period of report
Jun 5, 2026
Accepted (ET)
Jun 16, 2026 · 6:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001710072
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $35.59 | Jun 5, 2026 | A | 16,377 | A | Jun 2, 2027 | Jun 5, 2036 | Common Stock | 16,377 | 16,377 | D |
Explanation of responses
- F1100% of the Stock Options granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder.